Louis C. Lucido - Apr 3, 2023 Form 4 Insider Report for BioCorRx Inc. (BICX)

Role: Director, 10%+ Owner
Signature: /s/ Louis C. Lucido
Stock symbol: BICX
Transactions as of: Apr 3, 2023
Transactions value $: $299,768
Form type: 4
Date filed: 4/5/2023, 04:15 PM
Previous filing: Apr 3, 2023
Next filing: Jul 5, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BICX	Common Stock, par value $0.001	Purchase	$300K	+171K	+163.17%	$1.75	276K	Apr 3, 2023	By Trust	F1
transaction	BICX	Common Stock, par value $0.001	Other	$0	+184K	+66.46%	$0.00	460K	Apr 3, 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were issued to the Louis C Lucido and Carolyn M. Lucido, or their Successors, as Trustee of the Lucido Family Trust, Dated May 23, 2017, managed by Mr. Louis C Lucido (the "Lucido Trust") pursuant to a subscription agreement by and between BioCorRx Inc. and the Lucido Trust dated March 29 2023, and paid for on April 3, 2023. The Reporting Person may be deemed to have investment power over the Lucido Trust.
F2	These shares were issued to Mr. Lucido pursuant to an exchange agreement by and between BioCorRx Inc. (the "Company") and Mr. Lucido dated April 3, 2023 (the "Exchange Agreement"). Pursuant to the Exchange Agreement, the Company agreed to issue 183,606 shares of its common stock, par value $0.001 per share, to Mr. Lucido and Mr. Lucido agreed to exchange, surrender and cancel that certain promissory note dated November 1, 2022 held by Mr. Lucido in the aggregate amount of $313,892, including interest.

Content

These shares were issued to the Louis C Lucido and Carolyn M. Lucido, or their Successors, as Trustee of the Lucido Family Trust, Dated May 23, 2017, managed by Mr. Louis C Lucido (the "Lucido Trust") pursuant to a subscription agreement by and between BioCorRx Inc. and the Lucido Trust dated March 29 2023, and paid for on April 3, 2023. The Reporting Person may be deemed to have investment power over the Lucido Trust.

These shares were issued to Mr. Lucido pursuant to an exchange agreement by and between BioCorRx Inc. (the "Company") and Mr. Lucido dated April 3, 2023 (the "Exchange Agreement"). Pursuant to the Exchange Agreement, the Company agreed to issue 183,606 shares of its common stock, par value $0.001 per share, to Mr. Lucido and Mr. Lucido agreed to exchange, surrender and cancel that certain promissory note dated November 1, 2022 held by Mr. Lucido in the aggregate amount of $313,892, including interest.